Skip to content
2000
Volume 20, Issue 13
  • ISSN: 1389-2010
  • E-ISSN: 1873-4316

Abstract

The epidemiological impact of viral diseases, combined with the emergence and reemergence of some viruses, and the difficulties in identifying effective therapies, have encouraged several studies to develop new therapeutic strategies for viral infections. In this context, the use of immunotherapy for the treatment of viral diseases is increasing. One of the strategies of immunotherapy is the use of antibodies, particularly the monoclonal antibodies (mAbs) and multi-specific antibodies, which bind directly to the viral antigen and bring about activation of the immune system. With current advancements in science and technology, several such antibodies are being tested, and some are already approved and are undergoing clinical trials. The present work aims to review the status of mAb development for the treatment of viral diseases.

Loading

Article metrics loading...

/content/journals/cpb/10.2174/1389201020666190809112704
2019-11-01
2025-07-16
Loading full text...

Full text loading...

/content/journals/cpb/10.2174/1389201020666190809112704
Loading
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test